Oncomatryx

Derio, Spain

Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.

$26.3M raised

Jan 2025

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Oncomatryx raised?

Oncomatryx has raised $26.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.

Who are Oncomatryx's investors?

Oncomatryx's investors include Centre for the Development of Industrial Technology (CDTI), Gestion De Capital Riesgo Del Pais Vasco.

Where is Oncomatryx headquartered?

Oncomatryx is headquartered in Derio, Spain.

What does Oncomatryx do?

Oncomatryx is a biopharmaceutical company focused on the tumor microenvironment.

What stage is Oncomatryx at?

Oncomatryx is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 27, 2025.

MLA

"Oncomatryx — Funding & Investors." VCBacked, January 27, 2025, https://www.vcbacked.co/company/oncomatryx. Accessed July 2, 2026.

APA

VCBacked. (2025). Oncomatryx — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/oncomatryx

Wikipedia (cite web)

{{cite web |title=Oncomatryx — Funding & Investors |url=https://www.vcbacked.co/company/oncomatryx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 27, 2025.